Where do these answers come from?

For the substance and its human studies

The Food and Drug Administration (FDA) is the US agency that carries out medicine reviews. FDA’s BPC-157 review brings together the studies it found and explains their limits.

The evidence check for that review is dated September 28, 2026.

Read the conclusion beside the study description. Ask whether a result is about people, animals, or cells.

For the compounding position

FDA’s ingredient page has a separate table for requests to let pharmacies use an ingredient that were later taken back.

On the page marked current April 22, 2026, BPC-157 appears in that table, with concerns about harm still shown.

That page was checked on September 28, 2026. Taking a request back did not give ordinary pharmacies permission to use BPC-157.

For a doctor or pharmacy check

The medical boards’ federation links to the boards that license medical doctors. FDA links to state pharmacy licence searches through its BeSafeRx pages.

Use the record of the relevant board to check a name. These checks answer who holds a licence, not whether this treatment fits you.

For a study that is still planned

ClinicalTrials.gov records trial plans and status; registration does not mean a treatment has shown a benefit.

Look for results, not only the study’s description.